Response Biomedical Raises $11M in Offering | GenomeWeb

NEW YORK (GenomeWeb News) – Response Biomedical said today that it has grossed C$12.7 million ($11.1 million) through a public offering, and it plans to use the funds for general operating costs and for capital acquisitions.

The company said it issued 73,333,333 units at a price of C$0.15 per unit, and that it concurrently issued an additional 11 million units pursuant to the exercise-in-full of an over-allotment option it granted to the underwriter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.